Cat.#: ACPP-1782
| Despition | TPX E.coli |
| SIZE | 5 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile filtered liquid formulation 1 mg/ml. |
| Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1343 | GIRK1 Blocking Peptide (AC1343) | 250 µg | inquiry |
| ACPP-1249 | TMPRSS2 Blocking Peptide (AC1249) | 250 µg | inquiry |
| ACPP-1475 | Human MT3 Protein (AC1475) | 2 µg | inquiry |
| ACPP-1407 | Human HOMER3 Protein (AC1407) | 5 µg | inquiry |
| ACPP-1020 | Recombinant Human Neurotensin Protein (Fc Tag) (AC1020) | 50 µg | inquiry |
| ACPP-1400 | ACTH (AC1400) | 2 mg | inquiry |
| ACPP-1796 | Human GAP43 Protein (AC1796) | 2 µg | inquiry |
| ACPP-1318 | Orexin A Blocking Peptide (AC1318) | 250 µg | inquiry |
| ACPP-1476 | Human ENSA Protein (AC1476) | 5 µg | inquiry |
| ACPP-1311 | Human LIF Protein (AC1311) | 3 x 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.